DNDi’s interventions at the 72nd World Health Assembly.
Health Policy Watch [18 April 2019]
“DNDi: “Bench-to-bedside” approach needed for drug & vaccine response to global health crises”
Rio de Janeiro – 11 April 2019
The people affected by Chagas disease will claim this 14th of April as World Chagas Day in the hope of increasing global awareness, building on the progress already made against this disease, which has been neglected for more than a century
The International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS) has launched an online petition through the platform change.org in support of the official declaration of April 14th as their World Day. This proposal will be tabled at the 72nd World Health Assembly, to be held in Geneva at the end of May 2019. The particular date has been chosen because on that same day, 110 years ago, the Brazilian doctor Carlos Chagas confirmed the first case of the disease in a child, called Berenice Soares.
22 May 2019
- DNDi co-organizing – panel discussion to discuss the major hurdles preventing access to quality care and treatment and how the global health community can best move forwards to eradicate Chagas disease
5 April 2019
- Michelle Childs, Head of Policy Advocacy – discussion around the theme “Urgent Innovation – Policies and Practices for Effective Response to Global Health Crises”
Health Policy Watch [6 February 2019]
“Civil society request fair pricing for medicines, transparency, at WHO”
1 February 2019
A new research paper recently published by the AFD (Agence Française de Développement) examines how DNDi, a distinctive Product Development Partnership (PDP), can illustrate what can be presented as a “commons” in the area of public health.
Paris/Genève, 30 Janvier 2019
La République Démocratique du Congo (RDC) a délivré une autorisation de mise sur le marché au fexinidazole pour le traitement de la trypanosomiase humaine africaine (THA) ou maladie du sommeil causée par le parasite Trypanosoma brucei gambiense. Cette approbation ouvre la voie à la distribution du fexinidazole, cette année, dans les pays où la maladie du sommeil est endémique, sachant qu’une autre soumission réglementaire est également prévue en Ouganda.
ガンビア・トリパノソーマ (Trypanosoma brucei gambiense) によるヒト・アフリカ・トリパノソーマ症 (HAT、別名アフリカ睡眠病) の治療薬として、コンゴ民主共和国 (DRC) においてフェキシニダゾールの申請が承認されました。これにより、ウガンダで予定されている申請とともに、今年フェキシニダゾールを流行国において普及させる道が開かれました。
DNDi had 4 interventions planned at the 144th session of the WHO Executive Board.
Nature [23 January 2019]
“Neglected disease research funding hits record high”
23 January 2019
The annual G-FINDER report provides policy-makers, donors, researchers, and industry with a comprehensive analysis of global investment into R&D of new products to prevent, diagnose, control, or cure neglected diseases in developing countries. It gives an up-to-date analysis of how R&D investments are being allocated across 33 neglected diseases, and product types, funding trends over time, and where the potential gaps lie.
Estadão [23 January 2019]
“Investimento do País em doenças negligenciadas cai 42% entre 2016 e 2017” – “Country investment in neglected diseases fell 42% between 2016 and 2017”
19 February 2019
- Jean-François Alesandrini, Senior Advisor, External Affairs and Executive Office, and Florent M’Bo, HAT Platform Coordinator – discussion on access to medicine
23 January 2019
- Nathalie Strub-Wourgaft, NTD Director – panellist
15 November 2018
On November 15, 2018, members of the Chagas Clinical Research Platform and the Global Chagas Coalition, participating in the VIII Meeting of the Chagas Platform in Santa Cruz de la Sierra, Bolivia, signed this letter addressed to governments, organizations and donors requesting an intensification in the efforts to control and eliminate Chagas disease as a public health problem. In the last 10 years, there have been significant efforts in the fight against the disease. However, many challenges remain. Next 2019 marks the 110th anniversary since the discovery of the disease and constitutes an opportunity to call attention to people affected by the disease and pursue necessary actions.